Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Interleukin-4 receptor alpha polymorphisms in autoimmune myasthenia gravis in a Caucasian population.

Pál Z, Varga Z, Semsei Á, Reményi V, Rózsa C, Falus A, Illes Z, Buzás EI, Molnar MJ.

Hum Immunol. 2012 Feb;73(2):193-5. doi: 10.1016/j.humimm.2011.11.001. Epub 2011 Nov 12.

PMID:
22119518
2.

Oestrogen receptor alpha gene intronic polymorphisms and autoimmune myasthenia gravis in Caucasian women.

Pal Z, Gal A, Remenyi V, Tordai A, Molnar MJ.

Neuromuscul Disord. 2009 Dec;19(12):822-4. doi: 10.1016/j.nmd.2009.09.002. Epub 2009 Sep 29.

PMID:
19793653
3.

A novel galectin-1 and interleukin 2 receptor β haplotype is associated with autoimmune myasthenia gravis.

Pál Z, Antal P, Millinghoffer A, Hullám G, Pálóczi K, Tóth S, Gabius HJ, Molnár MJ, Falus A, Buzás EI.

J Neuroimmunol. 2010 Dec 15;229(1-2):107-11. doi: 10.1016/j.jneuroim.2010.07.015. Epub 2010 Aug 21.

PMID:
20728947
4.

The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis.

Chuang WY, Ströbel P, Belharazem D, Rieckmann P, Toyka KV, Nix W, Schalke B, Gold R, Kiefer R, Klinker E, Opitz A, Inoue M, Kuo TT, Müller-Hermelink HK, Marx A.

Genes Immun. 2009 Dec;10(8):667-72. doi: 10.1038/gene.2009.64. Epub 2009 Aug 20.

PMID:
19693092
5.

FcgammaRIIA and FcgammaRIIIB polymorphisms in myasthenia gravis.

Raknes G, Skeie GO, Gilhus NE, Aadland S, Vedeler C.

J Neuroimmunol. 1998 Jan;81(1-2):173-6.

PMID:
9521619
6.

Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects.

Heckmann JM, Morrison KE, Emeryk-Szajewska B, Strugalska H, Bergoffen J, Willcox N, Newsom-Davis J.

J Autoimmun. 1996 Apr;9(2):175-80.

PMID:
8738961
7.

Polymorphisms of interferon-gamma, interleukin-10, and interleukin-12 genes in myasthenia gravis.

Yilmaz V, Tütüncü Y, Bariş Hasbal N, Parman Y, Serdaroglu P, Deymeer F, Saruhan-Direskeneli G.

Hum Immunol. 2007 Jun;68(6):544-9. Epub 2007 Mar 12.

PMID:
17509455
8.

Stromal cell derived factor-1 genetic variation at locus 801 in patients with myasthenia gravis.

Yousefipour GA, Haghshenas MR, Yahyazadeh S, Erfani N.

Iran J Immunol. 2011 Jun;8(2):90-5. doi: IJIv8i2A4.

9.

Polymorphisms at - 174 and in the 3' flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis.

Huang D, Zheng C, Giscombe R, Matell G, Pirskanen R, Lefvert AK.

J Neuroimmunol. 1999 Nov 15;101(2):197-200.

PMID:
10580802
10.

Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients.

van der Pol WL, Jansen MD, Kuks JB, de Baets M, Leppers-van de Straat FG, Wokke JH, van de Winkel JG, van den Berg LH.

J Neuroimmunol. 2003 Nov;144(1-2):143-7.

PMID:
14597109
11.

Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial.

Schoof N, von Bonin F, Zeynalova S, Ziepert M, Jung W, Loeffler M, Pfreundschuh M, Trümper L, Kube D.

Ann Oncol. 2009 Sep;20(9):1548-54. doi: 10.1093/annonc/mdp110. Epub 2009 Jun 10.

12.

[Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism].

Mao HT, Wang XB, Zhang L, Gu HT.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Dec;21(6):574-8. Chinese. Retraction in: Mao HT, Wang XB, Zhang L, Gu HT. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Feb;23(1):99.

PMID:
15583985
13.

Association of HLA-A in autoimmune myasthenia gravis with thymoma.

Vandiedonck C, Raffoux C, Eymard B, Tranchant C, Dulmet E, Krumeich S, Gajdos P, Garchon HJ.

J Neuroimmunol. 2009 May 29;210(1-2):120-3. doi: 10.1016/j.jneuroim.2009.02.004. Epub 2009 Mar 10.

PMID:
19278738
14.

Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis.

Suzuki S, Kuwana M, Yasuoka H, Tanaka K, Fukuuchi Y, Kawakami Y.

J Neurol Sci. 2001 Aug 15;189(1-2):59-64.

PMID:
11535234
15.

Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.

Kida K, Hayashi M, Yamada I, Matsuda H, Yoshinaga J, Takami S, Yashiki S, Sonoda S.

Ann Neurol. 1987 Mar;21(3):274-8.

PMID:
3606034
16.

Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.

Yousefipour GA, Salami Z, Farjadian S.

Iran J Immunol. 2009 Jun;6(2):99-102. doi: IJIv6i2A6.

17.

FOXP3 -3279 and IVS9+459 polymorphisms are associated with genetic susceptibility to myasthenia gravis.

Zhang J, Chen Y, Jia G, Chen X, Lu J, Yang H, Zhou W, Xiao B, Zhang N, Li J.

Neurosci Lett. 2013 Feb 8;534:274-8. doi: 10.1016/j.neulet.2012.11.048. Epub 2012 Dec 7.

PMID:
23228687
18.

TNFA and TNFB polymorphisms in myasthenia gravis.

Skeie GO, Pandey JP, Aarli JA, Gilhus NE.

Arch Neurol. 1999 Apr;56(4):457-61.

PMID:
10199335
19.

Interleukin-10 promoter polymorphisms in myasthenia gravis.

Alseth EH, Nakkestad HL, Aarseth J, Gilhus NE, Skeie GO.

J Neuroimmunol. 2009 May 29;210(1-2):63-6. doi: 10.1016/j.jneuroim.2009.02.009. Epub 2009 Mar 18.

PMID:
19299022
20.

No evidence for interleukin-4 gene conferring susceptibility to myasthenia gravis.

Huang D, Xia S, Zhou Y, Pirskanen R, Liu L, Lefvert AK.

J Neuroimmunol. 1998 Dec 1;92(1-2):208-11.

PMID:
9916896

Supplemental Content

Support Center